Skip to main
NMAD

NMAD Market Capitalization Overview

Market Cap: $127.62M as of Jul 6, 2026

$127.62M
$40.94M (47.23%)past month
As of Jul 6, 2026, NMAD has a market capitalization of $127.62M. Over the past 30 days, its market cap has increased by 49.37%, while in the last 12 months, it has increased by 305.75%.

Market capitalization represents the total value of Lixte Biotechnology Holdings I as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

NMAD Market Cap Formula = Stock Price * Shares Outstanding

The market cap of NMADhelps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NMAD Market Cap History

DateMarket CapChange
Jul 1, 2026$133.36M+49.37%
Jun 1, 2026$89.29M+128.03%
May 1, 2026$39.16M+59.43%
Apr 1, 2026$24.56M+4.61%
Mar 2, 2026$23.48M-17.60%
Feb 2, 2026$28.50M-7.29%
Jan 2, 2026$30.74M+31.40%

NMAD End of Year Market Cap History

DateMarket CapChange
2026$127.62M+305.75%
2025$31.46M+588.92%
2024$4.57M-13.63%
2023$5.29M-37.62%
2022$8.48M-48.20%
2021$16.36M

FAQs About Lixte Biotechnology Holdings I (NMAD) Market Cap

As of Jul 6, 2026, the market capitalization of NMAD is $127.62M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Lixte Biotechnology Holdings I’s market capitalization has increased by 47.23%, changing from $86.69M to $127.62M as of Jul 6, 2026.

In the last 3 months, Lixte Biotechnology Holdings I’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Lixte Biotechnology Holdings I’s market capitalization increased from $4.57M in January to $31.46M in December, reflecting a 588.92% change.

In the past five years, NMAD has had a compound annual growth rate (CAGR) of 13.97% in market capitalization. This means its market cap has grown at an average rate of 13.97% per year.

Lixte Biotechnology Holdings I (NMAD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.